Inside the Senate bill

Inside the Senate bill

Summary BIO arguments
Would move drugs now covered under Part B(administered "incident" to a physician's service) into the new Medicare prescription drug benefit, which would require rebates Biotech drugs disproportionately affected because they are administered in large part through transfusion or injection "incident" to a physician's service.
Creates additional tax for biotech drugs already on market.

Read the full 607 word article

How to gain access

Continue reading with a
two-week free trial.